Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice today announced that the new standalone public company that will result from the planned spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice will be named Covetrus. The transaction is expected to be completed in the first quarter of 2019. The new company, Covetrus, will be a global, technology-enabled animal health business supporting the companion, equine and large-animal veterinary ma...